| Marcus Eugene Harrell, CRNA | |
|
101 W Ironwood Dr Ste 250, Coeur D Alene, ID 83814-1415 | |
| (208) 765-8585 | |
| Not Available |
| Full Name | Marcus Eugene Harrell |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 26 Years |
| Location | 101 W Ironwood Dr Ste 250, Coeur D Alene, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407959380 | NPI | - | NPPES |
| 050889 | Other | TX | CRNA LICENSE |
| 89607U | Other | TX | BCBS |
| 002958903 | Medicaid | TX | |
| 1457939380 | Medicaid | ID | |
| 625990 | Other | TX | TEXAS STATE NURSE LICENSE |
| P00719258 | Other | TX | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RNA-902A (Idaho) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 625990 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kootenai Health | Coeur d'alene, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Coeur D Alene Pllc | 2365427838 | 47 |
News Archive
Proteins are widely viewed as a promising alternative to synthetic chemicals in everything from medications to hand lotion.
InVivo Therapeutics today announced the Company's Platinum level sponsorship of the 6th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
WebMD Health Corp. announced today that it intends to commence a tender offer next week to purchase up to 3,000,000 shares of its common stock at a price per share of $50.00. The number of shares proposed to be purchased in the tender offer represents approximately 5.2% of WebMD's currently outstanding common shares. The NASDAQ Official Closing Price of WebMD's common stock on August 4, 2010 was $47.25 per share.
› Verified 3 days ago
| Entity Name | Anesthesia Associates Of Coeur D Alene Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962440966 PECOS PAC ID: 2365427838 Enrollment ID: O20040621000475 |
News Archive
Proteins are widely viewed as a promising alternative to synthetic chemicals in everything from medications to hand lotion.
InVivo Therapeutics today announced the Company's Platinum level sponsorship of the 6th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
WebMD Health Corp. announced today that it intends to commence a tender offer next week to purchase up to 3,000,000 shares of its common stock at a price per share of $50.00. The number of shares proposed to be purchased in the tender offer represents approximately 5.2% of WebMD's currently outstanding common shares. The NASDAQ Official Closing Price of WebMD's common stock on August 4, 2010 was $47.25 per share.
› Verified 3 days ago
| Entity Name | Benewah Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386632180 PECOS PAC ID: 1850200700 Enrollment ID: O20040927000265 |
News Archive
Proteins are widely viewed as a promising alternative to synthetic chemicals in everything from medications to hand lotion.
InVivo Therapeutics today announced the Company's Platinum level sponsorship of the 6th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
WebMD Health Corp. announced today that it intends to commence a tender offer next week to purchase up to 3,000,000 shares of its common stock at a price per share of $50.00. The number of shares proposed to be purchased in the tender offer represents approximately 5.2% of WebMD's currently outstanding common shares. The NASDAQ Official Closing Price of WebMD's common stock on August 4, 2010 was $47.25 per share.
› Verified 3 days ago
| Entity Name | Benewah Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1548320435 PECOS PAC ID: 1850200700 Enrollment ID: O20061104000136 |
News Archive
Proteins are widely viewed as a promising alternative to synthetic chemicals in everything from medications to hand lotion.
InVivo Therapeutics today announced the Company's Platinum level sponsorship of the 6th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
WebMD Health Corp. announced today that it intends to commence a tender offer next week to purchase up to 3,000,000 shares of its common stock at a price per share of $50.00. The number of shares proposed to be purchased in the tender offer represents approximately 5.2% of WebMD's currently outstanding common shares. The NASDAQ Official Closing Price of WebMD's common stock on August 4, 2010 was $47.25 per share.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marcus Eugene Harrell, CRNA 101 W Ironwood Dr Ste 250, Coeur D Alene, ID 83814-1415 Ph: (208) 765-8585 | Marcus Eugene Harrell, CRNA 101 W Ironwood Dr Ste 250, Coeur D Alene, ID 83814-1415 Ph: (208) 765-8585 |
News Archive
Proteins are widely viewed as a promising alternative to synthetic chemicals in everything from medications to hand lotion.
InVivo Therapeutics today announced the Company's Platinum level sponsorship of the 6th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
WebMD Health Corp. announced today that it intends to commence a tender offer next week to purchase up to 3,000,000 shares of its common stock at a price per share of $50.00. The number of shares proposed to be purchased in the tender offer represents approximately 5.2% of WebMD's currently outstanding common shares. The NASDAQ Official Closing Price of WebMD's common stock on August 4, 2010 was $47.25 per share.
› Verified 3 days ago
Joshua Leppert, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-765-8585 | |
Ms. Nuria M Martinez, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2204 Ironwood Pl Ste B, Coeur D Alene, ID 83814 Phone: 208-765-8585 | |
Ryan C Golob, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-666-2000 | |
Kevin M Knopp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-4000 | |
Richard J Gerhard, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1705 N Government Way, Coeur D Alene, ID 83814 Phone: 208-765-8585 Fax: 208-765-8486 | |
Joanna M Minetti, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 101 W Ironwood Dr Ste 250, Coeur D Alene, ID 83814 Phone: 208-765-8585 | |
Ms. Chelsea Faye Hubbard, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-4000 |